Brace yourself for hot peptide summer.
In late February, health secretary Robert F. Kennedy Jr. joined Joe Rogan on his podcast, revealing that that he’s directing the FDA to loosen regulations on over a dozen previously banned peptides. The move, which seems likely to be announced in the coming weeks, would largely reverse the FDA’s previous decision to place 19 peptides on the agency’s category 2 list, which effectively bans pharmacies from formulating them for human use—and, by extension, restricts doctors from prescribing them. (Not that the initial decision to ban these peptides prevented surging demand from fueling a booming black market online).
Read Full Article »